| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |